Ascendis Pharma A/S (ASND) Financial Statements & Analysis

Ascendis Pharma A/S (ASND) Income Statement

Ascendis Pharma A/S reported revenue of EUR 720.13M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 98.0% from EUR 363.64M a year earlier. Ascendis Pharma A/S posted a net loss of EUR 228.03M, compared with a net loss of EUR 378.08M a year earlier. Gross margin was 86.8% and operating margin -18.9%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was EUR 339.29M, up 114.7% from the same quarter a year earlier.

Ascendis Pharma A/S Income Statement Analysis

Values in millions EUR

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Ascendis Pharma A/S income statement - Annual data in millions EUR
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Jan 2023	Dec 2022	Dec 2021	Dec 2020	Mar 2020	Mar 2019	Dec 2017
Revenue & Gross Profit
Revenue	720.13	363.64	266.72	51.17	51.17	7.78	6.95	13.38	10.58	1.53
Cost of Revenue	94.92	44.26	44.40	12.14	12.14	3.52	0.00	0.00	0.00	0.00
Gross Profit	625.22	319.38	222.32	39.04	39.04	4.26	6.95	13.38	10.58	1.53
Operating Expenses
Research & Development	303.62	307.00	413.45	379.62	379.62	295.87	260.90	191.62	140.28	99.59
Selling, General & Administrative	448.04	284.08	258.79	221.23	215.85	160.18	76.67	48.47	25.06	13.48
Operating Expenses	761.49	598.15	677.86	-158.40	600.85	456.05	337.57	240.09	165.34	113.07
Operating Income	-136.27	-278.76	-455.54	-561.81	-561.81	-451.79	-330.62	-226.72	-154.76	-111.54
Other Income/Expense
Interest Income	15.30	14.36	16.86	52.18	7.43	0.69	1.81	10.06	4.02	0.92
Interest Expense	80.65	65.50	44.07	-30.68	30.68	3.91	1.92	1.22	0.13	0.10
Other Income/Expense	-31.50	-54.58	-18.60	84.97	7.25	67.85	-88.55	8.47	24.27	-12.83
Income
Income Before Tax	-212.65	-373.24	-474.14	-577.82	-577.82	-383.94	-419.17	-218.25	-130.49	-124.37
Income Tax Expense	15.38	4.84	7.30	5.38	5.38	-0.37	-0.22	-0.23	-0.39	-0.48
Net Income	-228.03	-378.08	-481.45	-583.19	-583.19	-383.58	-418.96	-218.02	-130.10	-123.90
Net Income - Continuous Operations	-228.03	-378.08	-481.45	-	-583.19	-383.58	-418.96	-218.02	-130.10	-123.90
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-
EBITDA	-114.31	-290.02	-411.17	-544.30	-529.18	-364.64	-407.81	-210.36	-150.18	-109.88
EBIT	-132.00	-307.74	-455.54	-561.81	-547.14	-451.79	-	-	-	-
Depreciation & Amortization	9.82	7.06	18.91	17.51	5.38	15.39	9.45	6.67	0.91	0.69
Earnings Per Share
Basic EPS	-4.00	-7.00	-9.00	-10.00	-10.00	-7.00	-8.00	-5.00	-3.00	-4.00
Diluted EPS	-4.00	-7.00	-9.00	-10.00	-10.00	-7.00	-8.00	-5.00	-3.00	-4.00
Basic Shares Outstanding	60.61	57.89	56.29	56.07	56.07	54.77	50.62	46.51	41.09	33.63
Diluted Shares Outstanding	60.61	57.89	56.29	56.07	56.07	54.77	50.62	46.51	41.09	33.63

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Ascendis Pharma A/S Financial Statements

What was Ascendis Pharma A/S's revenue in fiscal 2025?

Ascendis Pharma A/S reported revenue of EUR 720.13M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 98.0% from EUR 363.64M a year earlier.

Is Ascendis Pharma A/S profitable?

No. Ascendis Pharma A/S reported a net loss of EUR 228.03M in fiscal 2025. In fiscal 2024 it lost EUR 378.08M.

What is Ascendis Pharma A/S's operating margin?

Ascendis Pharma A/S's operating income was −EUR 136.27M on revenue of EUR 720.13M in fiscal 2025, an operating margin of -18.9%, compared with -76.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition